This Mesoblast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday

Comments
Loading...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Jefferies analyst David Stanton downgraded the rating for Mesoblast Limited MESO from Buy to Hold. Mesoblast shares closed at $14.63 on Friday. See how other analysts view this stock.
  • William Blair analyst Sami Corwin downgraded Applied Therapeutics, Inc. APLT from Outperform to Market Perform. Applied Therapeutics shares closed at $0.8801 on Friday. See how other analysts view this stock.
  • BTIG analyst Thomas Catherwood downgraded the rating for Innovative Industrial Properties, Inc. IIPR from Buy to Neutral. NCR Atleos shares closed at $73.66 on Friday. See how other analysts view this stock.

Considering buying MESO stock? Here’s what analysts think:

Read This Next:

Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!